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Pulmonary Hypertension
A Stage for Ventricular
Interdependence?*
Henry H. Hsia, MD, Francois Haddad, MD
Stanford, California
Once considered an uncommon disease, chronic thrombo-
embolic pulmonary hypertension (CTEPH) is now recog-
nized as a distinct clinical entity (1). Its pathophysiology
may be related to recurrent embolic events, in situ throm-
bosis, effects of vasoconstrictive mediators, immune-related
events, and ventricular remodeling (2–6). Changes in the
microvascular arteriopathy, similar to those seen in other
forms of pulmonary hypertension, may also account for
progressive clinical decline (7).
See page 2193
Heart failure associated with chronic right ventricular
(RV) pressure overload is a complex syndrome (8), with
ventricular hypertrophy, dilatation, and systolic failure. At a
cellular level, marked down-regulation of the -myosin
eavy chain (MHC) was observed with a reciprocal up-
egulation of its less active beta-isoform (beta-MHC). Such
hifts in cardiac myosin composition are associated with a
ecrease in contractility and have been seen in other
athologic conditions associated with myocardial failure
9–11). Significant RV dysfunction occurs with delayed
ctivation and repolarization, with down-regulation of var-
ous potassium currents (IK1, Ito1, and IKs) contributing to
ction potential duration (APD) prolongation in the RV
12,13). RV metabolism is also altered in the failing RV,
emonstrated by an increase in glucose uptake (14). This
as been the basis for an interesting field of research on
etabolic modulation in right heart failure (15).
However, ventricular dysfunction in the setting of chronic
V pressure overload is not just limited to the RV.
nterdependence between the RV and left ventricle (LV)
as first described by P.I. Bernheim in 1910. The “Bern-
eim effect” described RV failure in patients with aortic
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contents of this paper to disclose.tenosis, presumably due to the hypertrophied septum
ncroaching on the RV cavity (16). Similarly, RV dysfunc-
ion influencing LV hemodynamics in various clinical and
xperimental models has also been recognized. Such “re-
erse Bernheim effects” implies that RV pressure overload
eads to leftward bowing of the interventricular septum
uring diastole, thereby causing decreased LV chamber size,
ompliance, and contractility (17–19). However, the im-
aired LV function in the setting of chronic RV pressure
verload may not simply be the result of geometric effects of
V enlargement and LV chamber distortion by the Frank-
tarling mechanism. Effects of RV remodeling, notably
onduction slowing and AP prolongation, contribute to
engthening of the RV contraction duration and marked
elay in RV peak myocardial shortening and, consequently,
he onset of diastolic relaxation with respect to the septum
nd the LV, regardless of the presence of absence of right
undle branch block (20,21). Such interventricular mechan-
cal asynchrony and RV-to-LV diastolic interventricular
elay decrease LV filling and effective stroke volume. The
bnormal LV diastolic and systolic function is therefore in
arge part due to low LV preload and underfilling rather
han LV compression (17,20,22).
In clinical observations and animal studies of pulmonary
ypertension, ventricular interdependence is further mani-
ested by LV “atrophic” remodeling. Reductions in LV mass
nd expression of -MHC were observed as a consequence
f LV unloading (23). Similar atrophic LVs can also be
bserved in other conditions with chronic RV pressure
verload, such as rheumatic mitral stenosis (24) and end-
tage pulmonary emphysema (25), in which the LV is also
nderfilled. Normalization of RV function and LV diastolic
lling after mitral valvuloplasty and orthotopic lung trans-
lantation lead to significant increases in LV end-diastolic
olume, stroke volume, and restoration of LV mass. Simi-
arly, successful pulmonary thromboendarterectomy restores
he LV mass in patients with CTEPH (23).
Mechanical unloading in vivo induced profound electro-
hysiologic changes similar to that observed in pressure
verload induced hypertrophic phenotype (26). Whether
lectrophysiologic remodeling of the LV occurs in pressure
verload-induced RV failure is unknown. In this issue of the
ournal, Hardziyenka et al. (27) studied the LV electro-
hysiologic properties in rats with experimentally induced
ulmonary hypertension. Electrocardiographic and echocar-
iographic recordings, coupled with epicardial mapping in
angendorff-perfused hearts, histology analysis, patch
lamping, gene expression, and protein measurements of the
V in rats with pressure-induced RV failure were compared
ith controls. Moreover, intraoperative epicardial LV map-
ing was also performed in patients with CTEPH who
nderwent pulmonary endarterectomy.
The strength of this study resides in its multifaceted,
ell-designed experimental design. Echocardiographic evi-
ence of RV failure was associated with diminished LV
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demonstrated significantly prolonged QT intervals and LV
effective refractory periods (ERPs), along with markedly
reduced longitudinal conduction velocity in both patients
and animals with RV failure compared with controls.
To establish the cellular basis of ERP prolongation and
conduction slowing, cellular electrophysiology studies were
performed on isolated myocytes. LV myocytes from animals
with RV failure exhibited significantly prolonged APDs.
The mRNA expression of Kcnip2, which encodes a subunit
of the transient outward potassium current (Ito) was signif-
icantly reduced, in accordance with the observed AP/ERP
prolongations. In contrast, expression levels of other potas-
sium, sodium, and calcium channels remained unchanged.
Morphometric measurements showed the LV myocytes
were shorter and narrower compared with controls, consis-
tent with atrophic changes with reduction of LV mass. The
LV conduction slowing was not explained by impaired
impulse formation, as resting membrane potential, AP
amplitude/upstroke, and ionic currents were unaltered. In-
stead, impaired LV impulse transmission in RV failure was
related to both the reduction in cell size (28) and impaired
cell-to-cell impulse transmission. Quantification of the
connexin (Cx)-43 protein expression indicated a 24% de-
crease in the LV of experimental animals with RV failure.
Similarly, LVs of CTEPH patients also exhibited marked
ERP prolongation and conduction slowing, compared with
those without RV failure.
The current study highlights the much underappreciated
RV influence on LV function. It represents an extension of
previous investigations on the complex interactions between
the ventricles and provides insight into the mechanism of
LV remodeling. It is interesting that mechanical unloading
produces a similar phenotype as that of hemodynamic
overload. Down-regulation of the -MHC was observed in
oth hypertrophic failing RV myocytes and shrinking LV
yocytes in animal models of RV failure (11,23). LV
lectrophysiologic alterations induced by RV failure were
imilar to changes occurring in other forms of left heart
ailure (29,30). Despite an increase in the interstitial colla-
en deposition in the RV (but not in the LV), RV
onduction velocities were increased compared with con-
rols. This was associated with RV myocyte hypertrophy
nd a 30% increase in Cx-43 expression. Other investigators
ave demonstrated a greater degree of electrical abnormal-
ties in the RV compared with the LV. Such heterogeneity
n regional conduction velocities, prolongation of refracto-
iness, and abnormal dispersion of repolarization between
entricles favor the occurrence of early afterdepolarizations,
nd constitute the substrate for ventricular arrhythmias
11,31).
Clinical Implications
Pulmonary hypertension increases loading on the RV,
which can lead to electrical, mechanical, and structuralchanges. It sets the stage for ventricular interdependence,
resulting in LV unloading, dyssynchrony, and atrophic
remodeling. Pulmonary thromboendarterectomy offers a
potentially curative intervention for patients with CTEPH.
Successful surgery improves lung perfusion and reduces
pulmonary vascular resistance, and is associated with an
acceptable perioperative mortality in experienced centers
(3). RV afterload reduction results in recovery of RV systolic
function and improved LV preload. Restoration of LV
diastolic and systolic functions is associated with a normal-
ization of LV mass (22,23,32,33). These findings suggest
that atrophic LV remodeling may be reversible. Future
investigations should focus on innovative treatments to
minimize such secondary adaptation to abnormal LV un-
loading and mechanisms of “reverse remodeling.”
Because interventricular delay in systolic contraction and
diastolic relaxation occur in patients with CTEPH and
other forms of RV pressure overload, pre-exciting the RV
with RV pacing may provide resynchronization, minimize
diastolic interventricular delay, improve LV filling and
stroke volume (34). In addition to pulmonary hypertension,
RV pacing may be a viable treatment for RV failure in
congenital heart diseases (35–37). These studies offer proof-
of-concept of using RV pacing for treatment of right heart
failure. However, whether such RV resynchronization can
prevent LV remodeling is unknown. Replication of the
clinical observations with independent randomized trials to
assess long-term benefits and mortality reduction are still
required.
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